Quarterly report pursuant to Section 13 or 15(d)

Common Shares (Details)

v3.21.2
Common Shares (Details) - USD ($)
 1 Months Ended 3 Months Ended 8 Months Ended 9 Months Ended
Feb. 04, 2021
Dec. 09, 2020
Nov. 13, 2020
Sep. 17, 2020
Apr. 28, 2021
Apr. 23, 2021
Jan. 25, 2021
May 31, 2021
Dec. 10, 2020
May 31, 2020
May 28, 2021
May 31, 2021
May 31, 2020
Jun. 04, 2021
Nov. 11, 2020
Nov. 06, 2020
Aug. 07, 2020
Jul. 07, 2020
Common Shares (Details) [Line Items]
Common stock, shares issued and outstanding 485,554,914 485,554,914
Issued of stock 71,632,237
Settlement of trade debt (in Dollars) $ 3,433,200
Loss realized (in Dollars) $ 48,283
Issuance of common stock, shares 41,334,246
Restricted shares 1,000,000
Loss realized (in Dollars) $ (330,256)
Exercise price (in Dollars per share) $ 0.55 $ 0.0562 $ 0.0562 $ 0.0412
Various Investors [Member]
Common Shares (Details) [Line Items]
Issuance of common stock, shares 2,166,665
Various Investors [Member]
Common Shares (Details) [Line Items]
Issuance of common stock, shares 1,032,475 7,416,666
Stock value (in Dollars) $ 636,949
Convertible Debt [Member]
Common Shares (Details) [Line Items]
Issuance of common stock, shares 124,411,895
Stock value (in Dollars) $ 5,272,002
Loss realized (in Dollars) $ 397,090
Exercise price (in Dollars per share) $ 0.03
Warrant [Member]
Common Shares (Details) [Line Items]
Shares issued 2,268,169
Proceeds from warrant exercise 1,176,470
Exercise price (in Dollars per share) $ 0.03 $ 0.03
Warrants exercised of gross proceeds (in Dollars) $ 103,339 $ 103,339